Vedanta Biosciences announced preliminary results from the Phase 1a/1b clinical study in healthy volunteers for its lead, orally-administered live biotherapeutic product (LBP) candidate for recurrent Clostridium difficile infection (rCDI), VE303. With these Phase 1 data […]
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, today announced the appointment of Aoife Brennan, M.B., B.Ch., as president and chief executive officer of Synlogic, […]
Pivot Bio announced today $70 million in a Series B funding round led by Breakthrough Energy Ventures, and includes Singapore-headquartered investment company, Temasek. This funding further strengthens Pivot Bio’s 2019 commercial launch of the first […]
Following A-Mansia’s announcement of first close of Series A this April, Innovation Industries now joins the financing round of the microbiome company focused on developing products based on the unique properties of the Akkermansia muciniphila (A. […]
Second Genome, Inc., a clinical-stage company focused on the development of novel therapeutics identified through microbiome science, today announced the appointment of Karim Dabbagh, Ph.D., as president, chief executive officer, and a member of the […]
The DuPont Microbiome Venture and Global Health & Nutrition Science teams have worked in collaboration with the University of Virginia and 4Pharma Ltd in an experimental rhinovirus challenge to understand the role of nasal microbiota clusters and their […]
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, announced positive top-line results for its Phase Ib study of Thetanix in paediatric patients with Crohn’s disease. The study achieved its […]
The International Scientific Association for Probiotics and Prebiotics (ISAPP) has released a critique of two recent papers (here and here), which were published last week in the scientific journal Cell. The ISAPP Board of Directors, along […]
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and skin care, announces the formation of a 100% owned subsidiary, ProBiotix Health Limited (“ProBiotix”), and appointment of Adam […]
uBiome recently raised $83 million in Series C financing, with OS Fund leading the round, and participation from 8VC, Y Combinator, Dentsu Ventures, as well as additional new and existing investors. “This is the next […]
Evolve BioSystems, makers of Evivo® baby probiotic, today unveiled its prototype for the first-ever rapid-response infant gut microbiome screening test. Using a small stool sample collected from a diaper the test will detect levels of […]